Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | DXR | Stock Options (right to buy) | Award | $0 | +30K | $0.00 | 30K | Jul 11, 2023 | COMMON STOCK | 30K | $9.88 | Direct | F1, F2 |
Id | Content |
---|---|
F1 | Stock options granted on July 11, 2023 are contingent on the approval of the Securities & Exchange Commission ("SEC") to amend the Daxor Corporation 2020 Incentive Compensation Plan (the "Plan"). |
F2 | The stock options will vest in three installments on July 11, 2024 (10,000), July 11, 2025 (10,000) and July 11, 2026 (10,000) |